Ghassan Abou-Alfa, MD, JD, MBA - Accelerating Innovation In Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy and Targeted Platforms In Advanced Disease

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/CE/AAPA/IPCE information, and to apply for
credit, please visit us at PeerView.com/AAJ865.
CME/MOC/CE/AAPA/IPCE credit will be available until February 23,
2026.


Accelerating Innovation In Biliary Tract Cancer: Restructuring
Treatment Models With Immunotherapy & Targeted Platforms In
Advanced Disease


In support of improving patient care, this activity has been
planned and implemented by PVI, PeerView Institute for Medical
Education, and Cholangiocarcinoma Foundation. PVI, PeerView
Institute for Medical Education, is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by
independent medical education grants from AstraZeneca, Incyte
Corporation, Jazz Pharmaceuticals, and Taiho Oncology, Inc.


Disclosure information is available at the beginning of the video
presentation.